New pain drug kindolor tosylate tested in healthy volunteers – trial halted early
NCT ID NCT06243835
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tested the safety and how the body processes Kindolor Tosylate, a potential new drug for chronic pain. It involved 16 healthy adults who received either the drug or a placebo. The study was terminated, so full results are not available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Kindolor Tosylate
What this could lead to
If successful, this could lead to a new pain medication for chronic pain conditions.
What could go wrong
This was an early Phase 1 trial in healthy volunteers, not patients, and it was terminated, so results are limited. The drug may not work or may have safety issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Altman Clinical and Translational Research Institute
La Jolla, California, 92037, United States